|
|
|
|
|
|
|
|
126th MAINE LEGISLATURE |
|
|
LD 802 |
|
LR 1245(01) |
|
|
|
An Act To
Encourage Alternative Forms of Treatment for Opiate or Opioid Addiction by
Prohibiting MaineCare Coverage for Medication-assisted Treatment for
Addiction |
|
Preliminary
Fiscal Impact Statement for Original Bill |
|
Sponsor: Rep. Lockman of Amherst |
|
Committee: Health and Human Services |
|
Fiscal Note Required: Yes |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preliminary
Fiscal Impact Statement |
|
|
|
|
|
|
|
|
|
|
FY 2013-14 |
FY 2014-15 |
Projections FY 2015-16 |
Projections FY 2016-17 |
| Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$0 |
($2,433,062) |
($4,866,123) |
($4,866,123) |
|
|
|
|
|
|
|
| Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$0 |
($2,433,062) |
($4,866,123) |
($4,866,123) |
|
Federal Expenditures Fund |
|
$0 |
($3,937,044) |
($7,874,087) |
($7,874,087) |
|
|
|
|
|
|
|
| Fiscal Detail and Notes |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
The Department of
Health and Human Services will experience General Fund savings estimated to
be $2,433,062 in fiscal year 2014-15 due to the elimination of MaineCare
reimbursement for buprenorphine and naloxone combination drugs and methadone
for the treatment of addiction to opioids. |
|
|
|
|
|
|
|